ArticleMolecular neurobiology2025
Modulating NLRP3 Inflammasome Activity and Enhancing Cortical Synaptic Plasticity: Nanoparticulate Hydrogen's Role in Relief of Post-traumatic Anxiety-like Behaviors in Rats.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Post-traumatic stress disorder (PTSD) is a complex psychiatric disorder closely related to stress and traumatic events. Neuroinflammation and synaptic plasticity may play a role in the neurophysiological mechanisms of anxiety-like behaviors in PTSD. In this study, a novel magnesium hydrosilicide nanosheet (MSN) with anti-inflammatory and antioxidant properties was developed as a potential intervention for behavioral disorders associated with PTSD. Sustained hydrogen release was achieved through an optimized dosing regimen in a rat model subjected to single prolonged stress and electric foot shock (SPS&S), a validated paradigm for PTSD induction. Experimental results showed that a 7-day MSN intervention significantly attenuated anxiety-like behaviors while reversing the synaptic deficits induced by SPS&S in prefrontal cortical regions. Molecular analyses showed a concomitant downregulation of NOD-like receptor protein 3 (NLRP3) inflammasome components (protein as well as RNA levels) and restoration of neuroplasticity markers including brain-derived neurotrophic factor (BDNF) and postsynaptic density protein 95 (PSD95) protein levels. The therapeutic outcome correlated with the dual ability of hydrogen to inhibit pro-inflammatory signaling cascades and protect synaptic structures. These findings suggest that MSN-mediated hydrogen delivery is an effective strategy to address PTSD-associated affective dysfunction by orchestrating neuroimmune responses and synaptic homeostasis.
Indexed as
Identifiers
41261203What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.